Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma
Ofir GriessiD, Noa FurthiD, Nofar Harpaz, Nicoletta Di Bernardo, Tomer‐Meir SalameiD, Bareket DassaiD, Ioannis KaragiannidisiD, Yusuke IsshikiiD, Menachem GrossiD, Ari M. MelnickiD, Wendy BégueliniD, Guy RoniD, Efrat ShemaiD
Abstract
Diffuse large B cell lymphomas and follicular lymphomas show recurrent mutations in epigenetic regulators; among these are loss-of-function mutations in KMT2D and gain-of-function mutations in EZH2. To systematically explore the effects of these mutations on the wiring of the epigenetic network, we applied a single-cell approach to probe a wide array of histone modifications. We show that mutant-EZH2 elicits extensive effects on the epigenome of lymphomas, beyond alterations to H3K27 methylations, and is dominant over KMT2D mutations. Utilizing the single-cell data, we present computational methods to measure epigenetic heterogeneity. We identify an unexpected characteristic of mutant-EZH2, but not KMT2D, in increasing heterogeneity, shedding light on a novel oncogenic mechanism mediated by this mutation. Finally, we present tools to reconstruct known interactions within the epigenetic network, as well as reveal potential novel cross talk between various modifications, validated by functional perturbations. Our work highlights novel roles for mutant-EZH2 in lymphomagenesis and establishes new concepts for measuring epigenetic heterogeneity and intra-chromatin connectivity in cancer cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.44
- Field percentile
- top 20%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intravital single-cell behavior profiling reveals disrupted germinal center B cell motility and interactions by EZH2 gain-of-function mutation
Chanhong Min, Kibaek Choe, … Wendy Béguelin·bioRxiv·Sep 7, 2026
- EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
P. Romero, L. Richart, … R. Margueron·bioRxiv·Jan 2, 2023
- Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
M. Alqazzaz, G. Luciani, … D. Barsyte-Lovejoy·bioRxiv·Nov 20, 2023
- Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Ezh2Y641F Mutation in Hematopoiesis
Sarah M. Zimmerman, Samantha J. Procasky, … George P. Souroullas·Blood NeoplasiaPeer-reviewed·Jul 15, 2025
- Drug addiction mutations unveil a methylation ceiling in EZH2-mutant lymphoma
H. S. Kwok, A. M. Freedy, … B. Liau·bioRxiv·Apr 4, 2022
- Unmasking the cryptic immunopeptidome of EZH2 mutated diffuse large B-cell lymphomas through combination drug treatment
C. M. Bourne, S. S. Mun, … D. A. Scheinberg·bioRxiv·Sep 1, 2021